➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Mallinckrodt
Merck
AstraZeneca
Boehringer Ingelheim

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Metoprolol tartrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for metoprolol tartrate and what is the scope of freedom to operate?

Metoprolol tartrate is the generic ingredient in two branded drugs marketed by Novartis, Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Luitpold, Mylan Asi, Sandoz Inc, Watson Labs, West-ward Pharms Int, Us Pharms Holdings I, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Heritage Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Yaopharma Co Ltd, and Youngtech Pharms Inc, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for metoprolol tartrate. Fifty suppliers are listed for this compound.

Drug Prices for metoprolol tartrate

See drug prices for metoprolol tartrate

Drug Sales Revenue Trends for metoprolol tartrate

See drug sales revenues for metoprolol tartrate

Recent Clinical Trials for metoprolol tartrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Qilu Hospital of Shandong UniversityN/A
Corcept TherapeuticsPhase 1
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all metoprolol tartrate clinical trials

Pharmacology for metoprolol tartrate

US Patents and Regulatory Information for metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 074217-001 May 27, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Purepac Pharm METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 074380-002 Jul 29, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Mylan METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 076704-002 Jan 16, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 076704-001 Jan 16, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 073654-003 Dec 21, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984   Start Trial   Start Trial
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Medtronic
Boehringer Ingelheim
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.